Generic Drug Antitrust Lawsuit Expands

It is no secret that for two years Ct. Attorney General George Jepsen and his experienced antitrust division have been investigating and litigating against generic drug manufacturers. The case exploded this week with the announcement that 46 other attorneys general officially joined the case and asked a federal court to expand both the number of companies from six to eighteen and the number of drugs from two to fifteen. The potential liability to the generics companies is staggering, and the combined strength of 47 state attorneys general makes this one of the major cases pending in the country today.

• Press Release, Connecticut Attorney General, AG Jepsen Leads Coalition in New, Expanded Complaint in Federal Generic Drug Antitrust Lawsuit (Oct. 31, 2017).